American Renal Associates Holdings, Inc. Announces Launch of Secondary Public Offering of Common Stock

BEVERLY, Mass.--(BUSINESS WIRE)--American Renal Associates Holdings, Inc. (NYSE: ARA) (“ARA” or the “Company”), a provider of outpatient dialysis services, today announced the launch of an underwritten public offering of 5,000,000 shares of its common stock by certain stockholders (the “Selling Stockholders”), including Centerbridge Capital Partners, L.P. and certain of its affiliates. In addition, the Selling Stockholders are expected to grant to the underwriters in the offering a 30-day option to purchase up to an additional 750,000 shares of common stock at the public offering price, less the underwriting discount. ARA is not offering any stock in this offering and will not receive any proceeds from the sale of the shares of common stock by the Selling Stockholders.